ID   AG10A_HUMAN             Reviewed;         473 AA.
AC   Q5BKT4; Q6NS98; Q96DU0; Q96SM6;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 1.
DT   15-MAR-2017, entry version 116.
DE   RecName: Full=Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase;
DE            EC=2.4.1.256;
DE   AltName: Full=Alpha-1,2-glucosyltransferase ALG10-A;
DE   AltName: Full=Alpha-2-glucosyltransferase ALG10-A;
DE   AltName: Full=Asparagine-linked glycosylation protein 10 homolog A;
GN   Name=ALG10; Synonyms=ALG10A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Embryo;
RX   PubMed=12200473; DOI=10.1093/oxfordjournals.molbev.a004208;
RA   Oriol R., Martinez-Duncker I., Chantret I., Mollicone R., Codogno P.;
RT   "Common origin and evolution of glycosyltransferases using Dol-P-
RT   monosaccharides as donor substrate.";
RL   Mol. Biol. Evol. 19:1451-1463(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 149-473.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- FUNCTION: Adds the third glucose residue to the lipid-linked
CC       oligosaccharide precursor for N-linked glycosylation. Transfers
CC       glucose from dolichyl phosphate glucose (Dol-P-Glc) onto the
CC       lipid-linked oligosaccharide Glc(2)Man(9)GlcNAc(2)-PP-Dol.
CC   -!- CATALYTIC ACTIVITY: Dolichyl beta-D-glucosyl phosphate + D-Glc-
CC       alpha-(1->3)-D-Glc-alpha-(1->3)-D-Man-alpha-(1->2)-D-Man-alpha-
CC       (1->2)-D-Man-alpha-(1->3)-[D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-
CC       (D-Man-alpha-(1->2)-D-Man-alpha-(1->6))-D-Man-alpha-(1->6)]-D-Man-
CC       beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol = D-
CC       Glc-alpha-(1->2)-D-Glc-alpha-(1->3)-D-Glc-alpha-(1->3)-D-Man-
CC       alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-[D-Man-alpha-
CC       (1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-D-Man-alpha-(1->6))-
CC       D-Man-alpha-(1->6)]-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-
CC       GlcNAc-diphosphodolichol + dolichyl phosphate.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ALG10 glucosyltransferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB55272.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ312278; CAC41349.1; -; mRNA.
DR   EMBL; BC070347; AAH70347.1; -; mRNA.
DR   EMBL; BC090948; AAH90948.1; -; mRNA.
DR   EMBL; AK027657; BAB55272.1; ALT_INIT; mRNA.
DR   CCDS; CCDS41769.1; -.
DR   RefSeq; NP_116223.3; NM_032834.3.
DR   UniGene; Hs.102971; -.
DR   ProteinModelPortal; Q5BKT4; -.
DR   BioGrid; 124356; 22.
DR   IntAct; Q5BKT4; 3.
DR   STRING; 9606.ENSP00000266483; -.
DR   CAZy; GT59; Glycosyltransferase Family 59.
DR   iPTMnet; Q5BKT4; -.
DR   PhosphoSitePlus; Q5BKT4; -.
DR   BioMuta; ALG10; -.
DR   DMDM; 74736030; -.
DR   EPD; Q5BKT4; -.
DR   MaxQB; Q5BKT4; -.
DR   PaxDb; Q5BKT4; -.
DR   PeptideAtlas; Q5BKT4; -.
DR   PRIDE; Q5BKT4; -.
DR   DNASU; 84920; -.
DR   Ensembl; ENST00000266483; ENSP00000266483; ENSG00000139133.
DR   GeneID; 84920; -.
DR   KEGG; hsa:84920; -.
DR   UCSC; uc001rlm.4; human.
DR   CTD; 84920; -.
DR   DisGeNET; 84920; -.
DR   GeneCards; ALG10; -.
DR   H-InvDB; HIX0036775; -.
DR   HGNC; HGNC:23162; ALG10.
DR   HPA; HPA043329; -.
DR   HPA; HPA063387; -.
DR   MalaCards; ALG10; -.
DR   neXtProt; NX_Q5BKT4; -.
DR   OpenTargets; ENSG00000139133; -.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA134732019; -.
DR   eggNOG; KOG2642; Eukaryota.
DR   eggNOG; ENOG410YGXE; LUCA.
DR   GeneTree; ENSGT00390000012906; -.
DR   HOGENOM; HOG000240902; -.
DR   HOVERGEN; HBG053222; -.
DR   InParanoid; Q5BKT4; -.
DR   KO; K03850; -.
DR   OMA; RKVQPRH; -.
DR   OrthoDB; EOG091G0A27; -.
DR   PhylomeDB; Q5BKT4; -.
DR   TreeFam; TF300150; -.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   UniPathway; UPA00378; -.
DR   GenomeRNAi; 84920; -.
DR   PRO; PR:Q5BKT4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139133; -.
DR   CleanEx; HS_ALG10; -.
DR   ExpressionAtlas; Q5BKT4; baseline and differential.
DR   Genevisible; Q5BKT4; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004583; F:dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity; IEA:InterPro.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IEA:InterPro.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR016900; Alg10.
DR   PANTHER; PTHR12989; PTHR12989; 1.
DR   Pfam; PF04922; DIE2_ALG10; 1.
DR   PIRSF; PIRSF028810; Alpha1_2_glucosyltferase_Alg10; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Endoplasmic reticulum; Glycosyltransferase;
KW   Membrane; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    473       Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol
FT                                alpha-1,2-glucosyltransferase.
FT                                /FTId=PRO_0000215447.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     27       Helical. {ECO:0000255}.
FT   TOPO_DOM     28     64       Extracellular. {ECO:0000255}.
FT   TRANSMEM     65     85       Helical. {ECO:0000255}.
FT   TOPO_DOM     86     97       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     98    118       Helical. {ECO:0000255}.
FT   TOPO_DOM    119    130       Extracellular. {ECO:0000255}.
FT   TRANSMEM    131    151       Helical. {ECO:0000255}.
FT   TRANSMEM    152    172       Helical. {ECO:0000255}.
FT   TOPO_DOM    173    175       Extracellular. {ECO:0000255}.
FT   TRANSMEM    176    196       Helical. {ECO:0000255}.
FT   TOPO_DOM    197    249       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    250    270       Helical. {ECO:0000255}.
FT   TOPO_DOM    271    283       Extracellular. {ECO:0000255}.
FT   TRANSMEM    284    304       Helical. {ECO:0000255}.
FT   TOPO_DOM    305    323       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    324    344       Helical. {ECO:0000255}.
FT   TOPO_DOM    345    367       Extracellular. {ECO:0000255}.
FT   TRANSMEM    368    388       Helical. {ECO:0000255}.
FT   TOPO_DOM    389    392       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    393    413       Helical. {ECO:0000255}.
FT   TOPO_DOM    414    436       Extracellular. {ECO:0000255}.
FT   TRANSMEM    437    457       Helical. {ECO:0000255}.
FT   TOPO_DOM    458    473       Cytoplasmic. {ECO:0000255}.
FT   CONFLICT    184    184       M -> V (in Ref. 2; AAH70347).
FT                                {ECO:0000305}.
FT   CONFLICT    258    258       I -> T (in Ref. 1; CAC41349).
FT                                {ECO:0000305}.
FT   CONFLICT    384    384       I -> T (in Ref. 3; BAB55272).
FT                                {ECO:0000305}.
SQ   SEQUENCE   473 AA;  55606 MW;  1860D4E61ACBC2A0 CRC64;
     MAQLEGYYFS AALSCTFLVS CLLFSAFSRA LREPYMDEIF HLPQAQRYCE GHFSLSQWDP
     MITTLPGLYL VSIGVIKPAI WIFGWSEHVV CSIGMLRFVN LLFSVGNFYL LYLLFCKVQP
     RNKAASSIQR VLSTLTLAVF PTLYFFNFLY YTEAGSMFFT LFAYLMCLYG NHKTSAFLGF
     CGFMFRQTNI IWAVFCAGNV IAQKLTEAWK TELQKKEDRL PPIKGPFAEF RKILQFLLAY
     SMSFKNLSML LLLTWPYILL GFLFCAFVVV NGGIVIGDRS SHEACLHFPQ LFYFFSFTLF
     FSFPHLLSPS KIKTFLSLVW KRRILFFVVT LVSVFLVWKF TYAHKYLLAD NRHYTFYVWK
     RVFQRYETVK YLLVPAYIFA GWSIADSLKS KSIFWNLMFF ICLFTVIVPQ KLLEFRYFIL
     PYVIYRLNIP LPPTSRLICE LSCYAVVNFI TFFIFLNKTF QWPNSQDIQR FMW
//
